DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS  
BUREAU OF COMMUNITY AND HEALTH SYSTEMS  
SUBSTANCE USE DISORDERS SERVICE PROGRAM  
Filed with the secretary of state on September 3, 2020  
These rules take effect immediately upon filing with the secretary of state unless adopted under  
section 33, 44, or 45a(6) of the administrative procedures act of 1969, 1969 PA 306, MCL 24.233,  
24.244, or 24.245a. Rules adopted under these sections become effective 7 days after filing with the  
secretary of state.  
(By authority conferred on the director of the department of licensing and regulatory affairs by section  
6234 of the public health code, 1978 PA 368, MCL 333.6234, and Executive Reorganization Order  
Nos. 1991-3, 1994-1, 1996-1, 1996-2, 1997-4, 2009-1, and 2011-4,MCL 333.26321, 333.26322,  
330.3101, 445.2001, 333.26324, 333.26327, and 445.2030)  
R 325.1301of the Michigan Administrative Code is amended, as follows:  
PART 1. DEFINITIONS  
R 325.1301 Definitions.  
Rule 1301. (1) As used in these rules:  
(a) “Admission” means the point at which an individual is formally accepted into a  
substance use disorder services program and services are initiated.  
(b) “Aftercare” means the process of providing recommendations to a recipient for  
continued support after discharge from the program.  
(c) “Article 6” means article 6 of the public health code, 1978 PA 368, MCL 333.6230  
to 333.6251.  
(d) “Article 15” means article 15 of the public health code, 1978 PA 368, MCL  
333.16101 to 333.18838.  
(e) “Certified counselor” means an individual engaged in counseling of recipients in  
a substance use disorder services program who is certified as an alcohol and drug counselor  
by an organization approved and recognized by the department.  
(f) “Community change, alternatives, information, and training” or “CAIT” means  
prevention services offered by a substance use disorder services program.  
(g) “Complaint investigation” means a visit or an inspection of a licensee based upon  
a complaint with an allegation of noncompliance with or violation of the public health  
code, mental health code, or these rules.  
(h) “Department” means the department of licensing and regulatory affairs.  
(i) “Discharge” means the point at which the recipient's active involvement with a  
substance use disorder services program is terminated and the program has provided the  
necessary aftercare recommendations.  
(j) “Follow-up” means activities designed for a screening, assessment, referral, and  
follow up program to determine the present status of persons previously discharged by the  
program.  
(k) “Full-time” means employment of not less than 35 hours per week.  
(l) “Individual” means that term as defined in section 1105(1) of the public health  
August 13, 2020  
2
code, MCL 333.1105(1).  
(m) “Inpatient” means a full range of substance use disorder rehabilitation and  
treatment services that are provided to recipients admitted to a hospital and under medical  
direction.  
(n) “License” means a license issued by the department under article 6 of the public  
health code to establish, conduct, or maintain a substance use disorder services program.  
This term does not apply to a program located in a correctional institution, a veteran’s  
facility operated by the state or federal government, or a facility owned and operated by  
this state.  
(o) “Licensed counselor” means an individual engaged in counseling of recipients in  
a substance use disorder services program who is licensed under part 181 of the public  
health code, MCL 333.18101 to 333.18117, and is providing services in compliance with  
the scope of his or her license.  
(p) “Licensed master’s social worker” or “LMSW” means an individual engaged in  
counseling of recipients in a substance use disorder services program who is licensed under  
part 185 of the public health code, MCL 333.18501 to 333.18518, and is providing services  
in compliance with the scope of his or her license.  
(q) “Licensed psychologist” means an individual engaged in the practice of  
psychology of recipients in a substance use disorder services program who is licensed  
under part 182 of the public health code, MCL 333.18201 to 333.18237, and is providing  
services in compliance with the scope of his or her license.  
(r) “Licensee” means a person, as defined by section 1106(4), MCL 333.1106, who  
holds the license issued under article 6 of the public health code to operate a substance use  
disorder services program. Unless otherwise specified in these rules, a licensee does not  
include a person individually licensed under article 15 of the public health code, to provide  
psychological, medical, or social services through the individual’s license and whose  
recipients are limited to those of the individual licensed professional maintaining and  
operating the office.  
(s) “Licensure survey” means a non-complaint related visit or inspection to an  
applicant or licensee to evaluate compliance with the public health code, mental health  
code, or these rules.  
(t) “Medical director” means an individual licensed to engage in the practice of  
medicine or the practice of osteopathic medicine and surgery under part 170 or part 175 of  
the public health code, MCL 333.17001 to 333.17097 and 333.17501 to 333.17556.  
(u) “Medication assisted treatment” or “MAT” means the use of FDA approved  
drugs methadone, buprenorphine, or naltrexone in combination with counseling and  
behavioral therapy to provide treatment of substance use disorders.  
(v) “Mental health code” means the mental health code, 1974 PA 258, MCL  
330.1100 to 330.2106.  
(w) “Nurse” means a licensed practical nurse, registered professional nurse, or  
advanced practice registered nurse licensed under part 172 of the public health code, MCL  
333.17201 to 333.17242.  
(x) “Outpatient” means scheduled, periodic care, including diagnosis and therapy, in  
a nonresidential setting.  
(y) “Person” means that term as defined in section 1106(4) of the public health code,  
MCL 333.1106.  
(z) “Pharmacist” means an individual licensed to engage in the practice of  
3
pharmacy under article 15 of the public health code.  
(aa) “Physician” means an individual licensed to engage in the practice of medicine  
or the practice of osteopathic medicine and surgery under article 15 of the public health  
code.  
(bb) “Physician’s assistant” means an individual who is licensed to practice as a  
physician’s assistant under part 170 of the public health code, MCL 333.17001 to  
333.17097.  
(cc) “Public health code” means the public health code, 1978 PA 368, MCL 333.1101  
to 333.25211.  
(dd) “Recipient” means an individual who receives services from a licensed substance  
use disorder services program in this state.  
(ee) “Regional entity” means a coordinating agency designated by the state of  
Michigan to coordinate substance use disorder services in a specified region.  
(ff) “Residential” means a temporary or permanent live-in residential setting that  
provides continuous treatment and rehabilitation services. This term does not include  
recovery, transitional, or sober housing that provides only a residential setting without  
offering treatment and rehabilitation services but may offer prevention services.  
(gg) “Residential detoxification” means a residential, medically acute or subacute,  
systematic reduction of the amount of a drug in the body, or the elimination of a drug from  
the body concomitant.  
(hh) “Residential detoxification treatment positions” or “RDT positions” mean the  
number of recipients that can receive services at a residential detoxification program at the  
same time.  
(ii) “Screening and assessment, referral, follow-up” or “SARF” means the assessment  
of recipients through interviews, psychological tests, and other diagnostic or assessment  
tools, to diagnose substance use disorders and provide appropriate referrals for treatment  
and rehabilitative services, as necessary.  
(jj) “Staff” means an individual who is not a recipient and who works, with or without  
remuneration, for a licensed substance use disorder services program.  
(kk) “Substance use disorder services program” or “program” means a public or  
private person or entity offering or purporting to offer specific substance use disorder  
prevention, treatment, and rehabilitation services.  
(ll) “Substance” means an agent or a chemical that upon entering a human body alters  
the body's physical or psychological status, or both. This includes alcohol and other drugs.  
(mm) “Supervision” means that term as defined in section 16109(2) of the code, MCL  
333.16109.  
(nn) “United States Food & Drug Administration” or “FDA” means the federal agency  
of the United States Department of Health and Human Services.  
(2) A term defined in the public health code or the mental health code has the same  
meaning when used in these rules.  
;